In-Depth Research On:
Eli Lilly & Co (LLY)

Sign Up Now to Download a Free Research Report on LLY

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts

Select your areas of interest / would you like to receive the newsletter?




Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

Eli Lilly & Co

Eli Lilly & Co. shares spiked 5.14 percent to close at $58.09 a share Wednesday. The stock traded between $56.55 and $58.20 on volume 16.11 million shares traded. The company announced that ramucirumab met its primary endpoint of overall survival in a recent Phase III lung cancer trial. Shares of Eli Lilly are up approximately 14.0 percent year-to-date.

Going forward ... (see research report)


RESEARCH REPORT ON LLY
Download Free Report Now


Preview Pages of Actual Research Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on